Allurion Stock Soars 70% on Weight-loss Therapy Update

Seeking AlphaJan 23 18:07 ET

H.C. Wainwright Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $12

Moomoo NewsJan 22 11:31 ET · Ratings

Altimmune's Pemvidutide: A Promising Investment With Strong Buy Rating and Potential Revenue Growth

TipRanksJan 22 10:55 ET · Ratings

Jefferies Maintains Altimmune(ALT.US) With Buy Rating, Cuts Target Price to $28

Moomoo NewsJan 8 08:34 ET · Ratings

Evercore Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsJan 8 08:34 ET · Ratings

Evercore ISI Keeps Their Buy Rating on Altimmune (ALT)

TipRanksJan 8 08:17 ET · Ratings